(Q42690395)

4 November 2017

title

An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding (English)

1 reference

4 November 2017

David Mischoulon

1

1 reference

4 November 2017

Darin D Dougherty

2

1 reference

4 November 2017

Kathryn A Bottonari

3

1 reference

4 November 2017

Robert L Gresham

4

1 reference

4 November 2017

Shamsah B Sonawalla

5

1 reference

4 November 2017

Alan J Fischman

6

1 reference

4 November 2017

Maurizio Fava

7

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

4 November 2017

1 reference

4 November 2017

volume

116

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

151-161

1 reference

Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The effects of nefazodone on sleep architecture in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The importance of new antidepressants in the treatment of anxiety/depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

SPECT imaging of serotonin2 receptors in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Fluoxetine treatment of anger attacks: a replication study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

"Anger attacks": possible variants of panic and major depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Fenfluramine challenge in unipolar depression with and without anger attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Open trial of nefazodone for combat-related posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Striatal dopamine transporter density in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Limbic-cortical dysregulation: a proposed model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Sertraline-induced anorgasmia treated with intermittent nefazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Hepatic adverse reactions associated with nefazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

The Overt Aggression Scale for the objective rating of verbal and physical aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900082-3

7 January 2021

10.1016/S0925-4927(02)00082-3

Identifiers

DOI

1 reference

4 November 2017

1 reference